Who owns ATARA BIOTHERAPEUTICS INC?
- Ticker: ATRA
- CUSIP Number: 046513206
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold ATARA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 573k | $8.2M | 0% | Sep 2025 |
|
| Redmile Group | 442k | $6.3M | 0% | Sep 2025 |
|
| Vanguard Group | 203k | $2.9M | 7% | Sep 2025 |
|
| Marshall Wace | 116k | $1.7M | 173% | Sep 2025 |
|
| BlackRock | 70k | $1.0M | -1% | Sep 2025 |
|
| Mackenzie Financial | 64k | $915k | 183% | Sep 2025 |
|
| Geode Capital Management | 61k | $868k | 1% | Sep 2025 |
|
| Acadian Asset Management | 56k | $807k | -13% | Sep 2025 |
|
| Staley Capital Advisers | 50k | $717k | -33% | Sep 2025 |
|
| GSA Capital Partners | 26k | $376k | 34% | Sep 2025 |
|
| State Street Corporation | 25k | $362k | 0% | Sep 2025 |
|
| Jane Street | 22k | $316k | 100% | Sep 2025 |
|
| Renaissance Technologies | 19k | $271k | 12% | Sep 2025 |
|
| UBS Group | 17k | $248k | 106% | Sep 2025 |
|
| FMR | 17k | $246k | 0% | Sep 2025 |
|
| Cambridge Investment Research Advisors | 17k | $245k | 100% | Sep 2025 |
|
| Globeflex Capital | 16k | $222k | 100% | Sep 2025 |
|
| Morgan Stanley | 15k | $115k | 100% | Jun 2025 |
|
| Bridgeway Capital Management | 14k | $201k | 0% | Sep 2025 |
|
| Northern Trust | 11k | $158k | -1% | Sep 2025 |
|
| SBI Securities | 1.4k | $20k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 1.2k | $17k | -17% | Sep 2025 |
|
| Private Wealth Asset Management | 900.00 | $13k | 100% | Sep 2025 |
|
| Jones Financial Companies, L.L | 703.00 | $9.7k | 0% | Sep 2025 |
|
| Tower Research Capital | 342.00 | $4.9k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 251.00 | $3.6k | -74% | Sep 2025 |
|
| Jpmorgan Chase & Co | 216.00 | $3.1k | 0% | Sep 2025 |
|
| Rhumbline Advisers | 175.00 | $2.5k | 0% | Sep 2025 |
|
| Group One Trading | 148.00 | $2.1k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 50.00 | $716.000000 | 0% | Sep 2025 |
|
| KERR FINANCIAL PLANNING Corp | 24.00 | $322.000800 | 100% | Sep 2025 |
|
| Advisor Group Holdings | 10.00 | $138.000000 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 8.00 | $115.000000 | 100% | Sep 2025 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vestal Point Capital | Jun 2025 | 94k | $726k |
| Citadel Advisors | Jun 2025 | 23k | $178k |
| Raymond James Financial | Jun 2025 | 4.0k | $31k |